Overview
Christopher Dittus is a Hematologist Oncology specialist and an Emergency Medicine provider in Chapel Hill, North Carolina. Dr. Dittus has been practicing medicine for over 16 years and is rated as an Experienced provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Non-Hodgkin Lymphoma, Mantle Cell Lymphoma (MCL), Waldenstrom Macroglobulinemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Dittus is currently accepting new patients.
His clinical research consists of co-authoring 35 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- MEDICARE MAPD
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
101 Manning Dr, Chapel Hill, NC 27514
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
9 Clinical Trials
University Of North Carolina At Chapel Hill
William Wood is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Wood is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wood is currently accepting new patients.
University Of North Carolina At Chapel Hill
Hendrik Vandeventer is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Vandeventer is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Vandeventer is currently accepting new patients.
Duke Blood Cancer Center
I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. De Castro Iii is rated as a Distinguished provider by MediFind in the treatment of Aplastic Anemia. His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- B-Cell LymphomaDr. Dittus isDistinguished. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)Dr. Dittus isDistinguished. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).
- Large-Cell Immunoblastic LymphomaDr. Dittus isDistinguished. Learn about Large-Cell Immunoblastic Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Dittus isDistinguished. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Dittus isDistinguished. Learn about Non-Hodgkin Lymphoma.
- Waldenstrom MacroglobulinemiaDr. Dittus isDistinguished. Learn about Waldenstrom Macroglobulinemia.
- Advanced
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Dittus isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaDr. Dittus isAdvanced. Learn about Adult T-Cell Leukemia.
- Bone Marrow AspirationDr. Dittus isAdvanced. Learn about Bone Marrow Aspiration.
- Burkitt LymphomaDr. Dittus isAdvanced. Learn about Burkitt Lymphoma.
- Chronic T-Cell Leukemia (CTCL)Dr. Dittus isAdvanced. Learn about Chronic T-Cell Leukemia (CTCL).
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Dittus isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myelomonocytic LeukemiaDr. Dittus isExperienced. Learn about Acute Myelomonocytic Leukemia.
- AgranulocytosisDr. Dittus isExperienced. Learn about Agranulocytosis.
- Aleukemic Leukemia Cutis (ALC)Dr. Dittus isExperienced. Learn about Aleukemic Leukemia Cutis (ALC).
- Anaplastic Large Cell LymphomaDr. Dittus isExperienced. Learn about Anaplastic Large Cell Lymphoma.